Tenax turned into a $610.0M company without booking a single dollar of revenue in 2024 or 2025.
Shares closed at $15.55 on July 14, down 2.7% that day, after a six‑month rise of 17.0% and a twelve‑month jump of 168.2%. The company’s enterprise value sits at $512.4M, and the latest filings show no sales to underwrite that price.
<!-- embed: valuation snapshot -->
The stock’s week of trading underlines the point: July 7 closed at $17.36, July 8 at $17.72, July 9 at $18.30, July 10 at $17.56, July 13 at $15.99, and July 14 at $15.55. That kind of up‑and‑down move looks like buyers and sellers arguing about future milestones rather than reacting to current cash flows, because there aren’t any reported.
The company’s filings keep the present simple and procedural. On the legal front, Tenax lists routine litigation but says it doesn’t expect a material hit to the financials.
"Litigation The Company is subject to litigation in the normal course of business, none of which management believes will have a material adverse effect on the Company’s consolidated financial statements." (Company / 10-Q 2026-07-31)
The filing’s other quant note is tiny: a $0.1 million drop in interest income year over year tied to lower rates. It’s a concrete change, but not the kind of commercial metric that explains a nine‑figure market capitalization.
"Interest Income, Interest Expense, and Other Expense, net Interest income decreased by $0.1 million for the three months ended March 31, 2026, as compared to the same period in the prior year primarily due to lower interest rates." (Company / 10-Q 2026-05-12)
Filings also disclose a partner relationship with ORN. Beyond that relationship and the routine legal/interest items, the public paperwork shows no revenue, and nothing in the provided facts lists product sales or operating receipts for the last two reported fiscal years.
So here’s the tension in plain numbers: the market has put a nine‑figure valuation on a company whose last two annual revenues were both reported as $0.00. The share price and the filings tell two different parts of the story, one is market pricing, the other is the company’s current reported operations.
Both statements are factual: the market has pushed value up (12‑month gains, $610.0M market cap), and the company’s filings show zero reported revenue and only routine legal and interest notes. Which of those two facts will matter more next is for buyers and sellers to resolve.
Tenax reported $0.00 in revenue for fiscal years 2024 and 2025 and a market cap of $610.0M, per company filings.